Literature DB >> 33718167

The Prognostic Impact of Tumor Architecture for Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Weighted Analysis.

Hui-Ying Liu1, Yen Ta Chen1, Shun-Chen Huang2, Hung-Jen Wang1, Yuan-Tso Cheng1, Chih Hsiung Kang1, Wei Ching Lee1, Yu-Li Su3, Chun-Chieh Huang4, Yin-Lun Chang1, Yao-Chi Chuang1, Hao Lun Luo1, Po Hui Chiang1.   

Abstract

PURPOSE: To assess the association of tumor architecture with cancer recurrence, metastasis, and cancer-specific survival (CSS) in patients treated with radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC) in Taiwan.
MATERIALS AND METHODS: Data were collected from 857 patients treated with RNU between January 2005 and August 2016 in our hospital. Pathologic slides were reviewed by genitourinary pathologists. Propensity score weighting was performed for data analysis.
RESULTS: Sessile growth pattern was observed in 212 patients (24.7%). Tumor architecture exhibited a significant association with bladder cancer history, chronic kidney disease (CKD), tumor stage, lymph node status, histological grade, lymphovascular invasion, concomitant carcinoma in situ, and the variant type [standardized mean difference (SMD) > 0.1 for all variables before weighting]. In the propensity score analysis, 424 papillary and sessile tumor architecture were analyzed to balance the baseline characteristics between the groups. Tumor architecture was an independent predictor of metastatic disease and CSS (p = 0.033 and p = 0.002, respectively). However, the associations of tumor architecture with bladder and contralateral recurrence were nonsignificant (p = 0.956 and p = 0.844, respectively).
CONCLUSIONS: Tumor architecture of UTUC after RNU is associated with established features of aggressive disease and predictors of metastasis and CSS. Assessment of tumor architecture may help identify patients who could benefit from close follow-up or early administration of systemic therapy after RNU. Tumor architecture should be included in UTUC staging after further confirmation.
Copyright © 2021 Liu, Chen, Huang, Wang, Cheng, Kang, Lee, Su, Huang, Chang, Chuang, Luo and Chiang.

Entities:  

Keywords:  cancer-specific survival; metastasis; papillary; sessile; tumor architecture; upper urinary tract urothelial carcinoma

Year:  2021        PMID: 33718167      PMCID: PMC7947797          DOI: 10.3389/fonc.2021.613696

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  25 in total

Review 1.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

2.  Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.

Authors:  Vitaly Margulis; Ramy F Youssef; Pierre I Karakiewicz; Yair Lotan; Christopher G Wood; Richard Zigeuner; Eiji Kikuchi; Alon Weizer; Jay D Raman; Mesut Remzi; Marco Roscigno; Francesco Montorsi; Christian Bolenz; Wassim Kassouf; Shahrokh F Shariat
Journal:  J Urol       Date:  2010-06-17       Impact factor: 7.450

3.  Unusual clinical presentation of upper urothelial carcinoma in Taiwan.

Authors:  Y H Chou; C H Huang
Journal:  Cancer       Date:  1999-03-15       Impact factor: 6.860

Review 4.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas.

Authors:  Grégory Verhoest; Shahrokh F Shariat; Thomas F Chromecki; Jay D Raman; Vitaly Margulis; Giacomo Novara; Christian Seitz; Mesut Remzi; Morgan Rouprêt; Douglas S Scherr; Karim Bensalah
Journal:  World J Urol       Date:  2011-06-17       Impact factor: 4.226

5.  Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.

Authors:  Xiao-Peng Chen; Geng-Yan Xiong; Xue-Song Li; Surena F Matin; Maurice Garcia; Dong Fang; Tian-Yu Wang; Wei Yu; Kan Gong; Yi Song; Zhi-Song He; Qun He; Li-Qun Zhou
Journal:  BJU Int       Date:  2013-07-26       Impact factor: 5.588

6.  Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.

Authors:  Hans-Martin Fritsche; Giacomo Novara; Maximilian Burger; Amit Gupta; Kazumasa Matsumoto; Wassim Kassouf; Kanishka Sircar; Filiberto Zattoni; Tom Walton; Stefan Tritschler; Shiro Baba; Patrick J Bastian; Juan I Martínez-Salamanca; Christian Seitz; Wolfgang Otto; Wolf Ferdinand Wieland; Pierre I Karakiewicz; Vincenzo Ficarra; Arndt Hartmann; Shahrokh F Shariat
Journal:  Urol Oncol       Date:  2010-10-08       Impact factor: 3.498

7.  Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.

Authors:  Mesut Remzi; Andrea Haitel; Vitaly Margulis; Pierre Karakiewicz; Pierre Karakiewizc; Francesco Montorsi; Eiji Kikuchi; Richard Zigeuner; Alon Weizer; Christian Bolenz; Karim Bensalah; Nazareno Suardi; Jay D Raman; Yair Lotan; Matthias Waldert; Casey K Ng; Mario Fernández; Theresa M Koppie; Philipp Ströbel; Wareef Kabbani; Masaru Murai; Cord Langner; Marco Roscigno; Jeffrey Wheat; Charles C Guo; Christopher G Wood; Shahrokh F Shariat
Journal:  BJU Int       Date:  2008-10-16       Impact factor: 5.588

8.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

9.  Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.

Authors:  Vitaly Margulis; Shahrokh F Shariat; Surena F Matin; Ashish M Kamat; Richard Zigeuner; Eiji Kikuchi; Yair Lotan; Alon Weizer; Jay D Raman; Christopher G Wood
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

10.  The prognostic value of tumor architecture in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A systematic review and meta-analysis.

Authors:  Hu Zhao; Lijin Zhang; Bin Wu; Zhenlei Zha; Jun Yuan; Yuefang Jiang; Yejun Feng
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

View more
  2 in total

1.  DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma.

Authors:  Chien-Chang Kao; Yin-Lun Chang; Hui-Ying Liu; Sheng-Tang Wu; En Meng; Tai-Lung Cha; Guang-Huan Sun; Dah-Shyong Yu; Hao-Lun Luo
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

2.  The Prognostic Impact of Tumor Location in pT3N0M0 Upper Urinary Tract Urothelial Carcinoma: A Retrospective Cohort Study.

Authors:  Tzu Shuang Chen; Yen Ta Chen; Hung Jen Wang; Po Hui Chiang; Wen Chou Yang; Wei Ching Lee; Yao Chi Chuang; Yuan Tso Cheng; Chih Hsiung Kang; Wei Chia Lee; Chien Hsu Chen; Yuan Chi Shen; Yi Yang Liu; Hui Ying Liu; Yin Lun Chang; Yu Li Su; Chun Chieh Huang; Hao Lun Luo
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.